India to Pakistan: Omega Export Trade Route

The India to Pakistan Omega corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $1.0M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's omega manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $1.0M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with omega's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 24.4%, placing it at rank #20 among India's top omega export destinations globally.

On the import side, key buyers of Indian omega in Pakistan include ZUHOOR ELHAM LTD. ZUHOOR ELHAM LTD is the single largest importer with 1 shipments valued at $1.0M USD.

India's omega exports to Pakistan are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $1.0M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

On the buying side, ZUHOOR ELHAM LTD is the largest importer with 1 shipments worth $1.0M USD — representing 100% of all omega imports from India on this route.